Share Prices & Company Research

Stockbroking

Biopharma Credit Plc

Current Price 88.60p Bid 88.20p Ask 89.00p Change 0.91%
Last Updated: 09/05/2025 12:48. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

BioPharma Credit plc provides investors with an opportunity to gain exposure to the fast growing life sciences industry, through a diversified portfolio of loans and other instruments backed by royalties or other cash flows derived from sales of approved life sciences products. BioPharma Credit's primary objective is to generate predictable income for shareholders over the long term.

Key Personnel

Mr Colin Bond
Director
Mr Duncan W A Budge
Director
Mr Harry Abraham Hyman
Director
Ms Stephanie Léouzon
Non-Executive Director

Stock Details

EPIC
BPCRL
ISIN
GB00BDGKMY29
Shares in Issue
0.00m
Market cap
£0.00m

Analyst Views (0)

Strong Buy
 
0%
Buy
 
0%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
88.60p
Bid Price
88.20p
Ask Price
89.00p
Volume
9,186
Change Today
0.80p
% Change Today
0.91%
Open
88.60p
Previous Close
87.80p
Intraday High
88.60p
Intraday Low
88.60p
52 Week High
93.00p
52 Week Low
80.80p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.